Gunpo, South Korea

Seong-Won Song

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Autophagysciences Inc.. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seong-Won Song. Retrieved from https://idiyas.com/inventor/seong-won-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Seong-Won Song: Innovator in Autophagy-Related Pharmaceuticals

Introduction

Seong-Won Song is a notable inventor based in Gunpo-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of autophagy regulation. With a total of two patents to his name, his work is paving the way for advancements in medical treatments.

Latest Patents

Seong-Won Song's latest patents include a novel compound and a pharmaceutical composition that activates autophagy. This compound is valuable for preventing or treating diseases associated with autophagy regulation. Another patent focuses on a catechol derivative, which can also be used for the prevention or treatment of autophagy-related diseases. These innovations highlight his commitment to addressing critical health issues through scientific research.

Career Highlights

Throughout his career, Seong-Won Song has been associated with Autophagysciences Inc., where he continues to develop groundbreaking pharmaceutical solutions. His expertise in the field has positioned him as a key player in the research and development of treatments that target autophagy-related conditions.

Collaborations

Seong-Won Song has collaborated with notable colleagues, including Jung Ju Kim and Hwan Mook Kim. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.

Conclusion

Seong-Won Song's contributions to the field of pharmaceuticals, particularly in autophagy-related research, demonstrate his dedication to improving health outcomes. His innovative patents and collaborative efforts are significant steps toward advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…